LGC acquires Berry & Associates

News (ZH) - LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of Berry and Associates, premier supplier of specialty oligo reagents.

LGC acquires LINK and strengthens its oligo reagents offering

News (ZH) - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

NML appointed as expert laboratory for viral EQA schemes by INSTAND e.V.

News (ZH) - Appointment recognises world-leading expertise in the field of digital PCR for nucleic acid quantification.

LGC and AutoGen combine unique offerings for expanding markets

News (ZH) - Formalised distribution agreement across Europe, the Middle East and Africa

Bolstering COVID diagnostics and research by reducing risks of contamination

博客 - We support scientists on the front line of human healthcare with our custom manufacturing of components for (q)PCR- and NGS-based diagnostics.

LGC and Aptahem combine on first large-scale production campaign of Apta-1

News (ZH) - First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

LGC to develop new Berlin site to expand Nucleic Acid Therapeutics capacity

News (ZH) - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics